Magnetic field-controlled gene expression in encapsulated cells

Journal of Controlled Release

Volumn 158, Issue 3, 2012, Pages 424-432

  Ortner, Viktoria ^a,b   Kaspar, Cornelius ^b   Halter, Christian ^a   Töllner, Lars ^b,e   Mykhaylyk, Olga ^c   Walzer, Johann ^a   Günzburg, Walter H ^b   Dangerfield, John A ^b,d   Hohenadl, Christine ^b   Czerny, Thomas ^a,b  

^a Fachhochschule Campus Wien   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Christian Doppler Laboratory Foreign Module for Virology Nanotechnology   (Singapore)

^e AUSTRIAN CENTRE OF INDUSTRIAL BIOTECHNOLOGY   (Austria)

Author keywords

Cell encapsulation; Cell therapy; Gene therapy; Hyperthermia; Inducible gene expression; Magnetic nanoparticles

Indexed keywords

CELL ENCAPSULATIONS; CELL THERAPY; HYPERTHERMIA; INDUCIBLE GENE EXPRESSION; MAGNETIC NANOPARTICLES;

CYTOLOGY; ENCAPSULATION; GENE EXPRESSION; GENE THERAPY; HYPERTHERMIA THERAPY; MAGNETIC FIELDS; NANOPARTICLES;

CELLS;

MAGNETIC NANOPARTICLE;

ARTICLE; CELL ENCAPSULATION; CELL STRAIN HEK293; CELL VIABILITY; GENE CONSTRUCT; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HEAT SHOCK RESPONSE; HEAT TREATMENT; HEATING; HUMAN; HUMAN CELL; HYPERTHERMIA; MAGNETIC FIELD; PRIORITY JOURNAL; REPORTER GENE; THERMOGENESIS;

FERRIC COMPOUNDS; GENE EXPRESSION REGULATION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEAT-SHOCK PROTEINS; HEK293 CELLS; HUMANS; HYPERTHERMIA, INDUCED; LUCIFERASES; MAGNETIC FIELDS; METAL NANOPARTICLES; POLYMERS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 84859268967     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.12.006     Document Type: Article

References (47)

1. D. Emery Gene therapy for genetic diseases: on the horizon Clin. Appl. Immunol. Rev. 4 2004 411 422 (Pubitemid 40267861)
2. W.H. Gunzburg, and B. Salmons Stem cell therapies: on track but suffer setback Curr. Opin. Mol. Ther. 11 2009 360 363
3. O. Hauser, E. Prieschl-Grassauer, and B. Salmons Encapsulated, genetically modified cells producing in vivo therapeutics Curr. Opin. Mol. Ther. 6 2004 412 420 (Pubitemid 39207132)
4. M. Lohr, A. Hoffmeyer, J. Kroger, M. Freund, J. Hain, A. Holle, P. Karle, W.T. Knofel, S. Liebe, P. Muller, H. Nizze, M. Renner, R.M. Saller, T. Wagner, K. Hauenstein, W.H. Gunzburg, and B. Salmons Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma Lancet 357 2001 1591 1592 (Pubitemid 32488821)
5. B. Salmons, O. Hauser, W. Günzburg, and W. Tabotta GMP production of an encapsulated cell therapy product: issues and considerations Bioprocess. J. 6 2007 37 44
6. K. Stieger, B. Belbellaa, C. Le Guiner, P. Moullier, and F. Rolling In vivo gene regulation using tetracycline-regulatable systems Adv. Drug Deliv. Rev. 61 2009 527 541
7. S.Y. Tsai, B.W. O'Malley, F.J. DeMayo, Y. Wang, and S.S. Chua A novel RU486 inducible system for the activation and repression of genes Adv. Drug Deliv. Rev. 30 1998 23 31 (Pubitemid 28201902)
8. R.I. Morimoto Dynamic remodeling of transcription complexes by molecular chaperones Cell 110 2002 281 284
9. W. Walther, and U. Stein Heat-responsive gene expression for gene therapy Adv. Drug Deliv. Rev. 61 2009 641 649
10. V. Sokolova, and M. Epple Inorganic nanoparticles as carriers of nucleic acids into cells Angew. Chem. Int. Ed. Engl. 47 2008 1382 1395
11. Q.A.C. Pankhurst, J, S.K. Jones, and J. Dobson Applications of magnetic nanoparticles in biomedicine J. Phys. D: Appl. Phys. 36 2003 R176 R181
12. D. Stamopoulos, E. Manios, V. Gogola, D. Niarchos, and M. Pissas On the biocompatibility of Fe3O4 ferromagnetic nanoparticles with human blood cells J. Nanosci. Nanotechnol. 10 2010 6110 6115
13. S.J. Soenen, and M. De Cuyper Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects Nanomedicine (Lond.) 5 2010 1261 1275
14. M. Mahmoudi, S. Laurent, M.A. Shokrgozar, and M. Hosseinkhani Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles ACS Nano 5 2011 7263 7276
15. P. Wust, B. Hildebrandt, G. Sreenivasa, B. Rau, J. Gellermann, H. Riess, R. Felix, and P.M. Schlag Hyperthermia in combined treatment of cancer Lancet Oncol. 3 2002 487 497 (Pubitemid 34863670)
16. O. Mykhaylyk, Y.S. Antequera, D. Vlaskou, and C. Plank Generation of magnetic nonviral gene transfer agents and magnetofection in vitro Nat. Protoc. 2 2007 2391 2411
17. C. Plank, and J. Rosenecker Magnetofection: the use of magnetic nanoparticles for nucleic acid delivery 2009 Cold Spring Harb Protoc pdb prot5230
18. C. Plank, F. Scherer, U. Schillinger, C. Bergemann, and M. Anton Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields J. Liposome Res. 13 2003 29 32 (Pubitemid 36373341)
19. M. Mahmoudi, V. Serpooshan, and S. Laurent Engineered nanoparticles for biomolecular imaging Nanoscale 3 2011 3007 3026
20. A. Hanini, A. Schmitt, K. Kacem, F. Chau, S. Ammar, and J. Gavard Evaluation of iron oxide nanoparticle biocompatibility Int. J. Nanomedicine 6 2011 787 794
21. B. Bajoghli, N. Aghaallaei, T. Heimbucher, and T. Czerny An artificial promoter construct for heat-inducible misexpression during fish embryogenesis Dev. Biol. 271 2004 416 430 (Pubitemid 38833671)
22. C. Metzner, B. Salmons, W.H. Gunzburg, M. Gemeiner, I. Miller, B. Gesslbauer, A. Kungl, and J.A. Dangerfield MMTV accessory factor Naf affects cellular gene expression Virology 346 2006 139 150 (Pubitemid 43254706)
23. R. Klein, B. Ruttkowski, S. Schwab, T. Peterbauer, B. Salmons, W.H. Gunzburg, and C. Hohenadl Mouse mammary tumor virus promoter-containing retroviral promoter conversion vectors for gene-directed enzyme prodrug therapy are functional in vitro and in vivo J. Biomed. Biotechnol. 2008 2008 683505
24. M. Paar, S. Schwab, D. Rosenfellner, B. Salmons, W.H. Gunzburg, M. Renner, and D. Portsmouth Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors J. Virol. 81 2007 6973 6983 (Pubitemid 46986633)
25. T. Sugimoto, and E. Matiievic Formation of uniform spherical magnetite particles by crystallization from ferrous hydroxide gels J. Colloid Interface Sci. 74 1980 227 243
26. O. Mykhaylyk, Y. Sanchez-Antequera, D. Vlaskou, E. Hammerschmid, M. Anton, O. Zelphati, and C. Plank Liposomal magnetofection Methods Mol. Biol. 605 2010 487 525
27. O.V. Mykhaylyk, D., N. Tresilwised, P. Pithayanukul, W. Möller, and C. Plank Magnetic nanoparticle formulations for DNA and siRNA delivery J. Magn. Mat. 311 2007 275 281 (Pubitemid 46401036)
28. H. Dautzenberg, U. Schuldt, G. Grasnick, P. Karle, P. Muller, M. Lohr, M. Pelegrin, M. Piechaczyk, K.V. Rombs, W.H. Gunzburg, B. Salmons, and R.M. Saller Development of cellulose sulfate-based polyelectrolyte complex microcapsules for medical applications Ann. N. Y. Acad. Sci. 875 1999 46 63 (Pubitemid 29349061)
29. K. Balakrishnan, and A. De Maio Heat shock protein 70 binds its own messenger ribonucleic acid as part of a gene expression self-limiting mechanism Cell Stress Chaperones 11 2006 44 50 (Pubitemid 43363824)
30. U. Stein, J. Smith, W. Walther, and F. Arlt MACC1 controls Met: what a difference an Sp1 site makes Cell Cycle 8 2009 2467 2469
31. U.O. Hafeli, J.S. Riffle, L. Harris-Shekhawat, A. Carmichael-Baranauskas, F. Mark, J.P. Dailey, and D. Bardenstein Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery Mol. Pharm. 6 2009 1417 1428
32. M. Mahmoudi, A. Simchi, M. Imani, M.A. Shokrgozar, A.S. Milani, U.O. Hafeli, and P. Stroeve A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles Colloids Surf. B Biointerfaces 75 2010 300 309
33. C. Plank, M. Anton, C. Rudolph, J. Rosenecker, and F. Krotz Enhancing and targeting nucleic acid delivery by magnetic force Expert. Opin. Biol. Ther. 3 2003 745 758 (Pubitemid 36934974)
34. T.M. Chang Semipermeable microcapsules Science 146 1964 524 525
35. A. Al-Hendy, G. Hortelano, G.S. Tannenbaum, and P.L. Chang Growth retardation-an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts Hum. Gene Ther. 7 1996 61 70 (Pubitemid 26119484)
36. S.R. Winn, J.P. Hammang, D.F. Emerich, A. Lee, R.D. Palmiter, and E.E. Baetge Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons Proc. Natl. Acad. Sci. U. S. A. 91 1994 2324 2328 (Pubitemid 24092096)
37. P. Aebischer, N.A. Pochon, B. Heyd, N. Deglon, J.M. Joseph, A.D. Zurn, E.E. Baetge, J.P. Hammang, M. Goddard, M. Lysaght, F. Kaplan, A.C. Kato, M. Schluep, L. Hirt, F. Regli, F. Porchet, and N. De Tribolet Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF Hum. Gene Ther. 7 1996 851 860 (Pubitemid 26146442)
38. J. Bloch, A.C. Bachoud-Levi, N. Deglon, J.P. Lefaucheur, L. Winkel, S. Palfi, J.P. Nguyen, C. Bourdet, V. Gaura, P. Remy, P. Brugieres, M.F. Boisse, S. Baudic, P. Cesaro, P. Hantraye, P. Aebischer, and M. Peschanski Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study Hum. Gene Ther. 15 2004 968 975 (Pubitemid 39372573)
39. Y. Saitoh, T. Taki, N. Arita, T. Ohnishi, and T. Hayakawa Cell therapy with encapsulated xenogeneic tumor cells secreting beta-endorphin for treatment of peripheral pain Cell Transplant. 4 Suppl 1 1995 S13 S17
40. B. Sommer, C. Rinsch, E. Payen, B. Dalle, B. Schneider, N. Deglon, A. Henri, Y. Beuzard, and P. Aebischer Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts Mol. Ther. 6 2002 155 161 (Pubitemid 36336122)
41. J.L. Nordstrom The antiprogestin-dependent GeneSwitch system for regulated gene therapy Steroids 68 2003 1085 1094 (Pubitemid 37532434)
42. C. Rome, F. Couillaud, and C.T. Moonen Spatial and temporal control of expression of therapeutic genes using heat shock protein promoters Methods 35 2005 188 198 (Pubitemid 40092645)
43. A. Giombini, V. Giovannini, A. Di Cesare, P. Pacetti, N. Ichinoseki-Sekine, M. Shiraishi, H. Naito, and N. Maffulli Hyperthermia induced by microwave diathermy in the management of muscle and tendon injuries Br. Med. Bull. 83 2007 379 396 (Pubitemid 47614261)
44. E. Guilhon, P. Voisin, J.A. de Zwart, B. Quesson, R. Salomir, C. Maurange, V. Bouchaud, P. Smirnov, H. de Verneuil, A. Vekris, P. Canioni, and C.T. Moonen Spatial and temporal control of transgene expression in vivo using a heat-sensitive promoter and MRI-guided focused ultrasound J. Gene Med. 5 2003 333 342 (Pubitemid 40310385)
45. B. Thiesen, and A. Jordan Clinical applications of magnetic nanoparticles for hyperthermia Int. J. Hyperthermia 24 2008 467 474
46. G. Orive, and J.L. Pedraz Highlights and trends in cell encapsulation Adv. Exp. Med. Biol. 670 2010 1 4
47. B. Salmons, E.M. Brandtner, K. Hettrich, W. Wagenknecht, B. Volkert, S. Fischer, J.A. Dangerfield, and W.H. Gunzburg Encapsulated cells to focus the metabolic activation of anticancer drugs Curr. Opin. Mol. Ther. 12 2010 450 460